Met Life Investment Management, LLC Vor Biopharma Inc. Transaction History

Met Life Investment Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$3.09 - $5.33 $65,477 - $112,942	21,190 New	21,190 $65,000
Q2 2023 Aug 10, 2023	BUY	$3.09 - $5.33 $65,477 - $112,942	21,190 New	21,190 $65,000
Q1 2022 May 12, 2022	SELL	$6.04 - $12.23 $49,938 - $101,117	-8,268 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$11.32 - $18.02 $93,593 - $148,989	8,268 New	8,268 $96,000
Q3 2021 May 17, 2024	BUY	$12.24 - $20.38 $33,598 - $55,943	2,745 Added 49.7%	8,268 $129,000
Q3 2021 Jun 21, 2023	BUY	$12.24 - $20.38 $101,200 - $168,501	8,268 New	8,268 $129,000
Q3 2021 Mar 22, 2023	BUY	$12.24 - $20.38 $33,598 - $55,943	2,745 Added 49.7%	8,268 $129,000
Q3 2021 Nov 15, 2021	BUY	$12.24 - $20.38 $101,200 - $168,501	8,268 New	8,268 $130,000
Q2 2021 Aug 16, 2021	SELL	$18.65 - $38.78 $103,003 - $214,181	-5,523 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$30.96 - $54.08 $170,992 - $298,683	5,523 New	5,523 $238,000
Q1 2021 Jun 26, 2023	BUY	$30.96 - $54.08 $170,992 - $298,683	5,523 New	5,523 $238 Million
Q1 2021 Mar 22, 2023	BUY	$30.96 - $54.08 $170,992 - $298,683	5,523 New	5,523 $238,000
Q1 2021 May 14, 2021	BUY	$30.96 - $54.08 $170,992 - $298,683	5,523 New	5,523 $238,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.